165 related articles for article (PubMed ID: 6406781)
1. Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels.
Clemens JA; Bennett DR; Black LJ; Jones CD
Life Sci; 1983 Jun; 32(25):2869-75. PubMed ID: 6406781
[TBL] [Abstract][Full Text] [Related]
2. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Gottardis MM; Jordan VC
Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
[TBL] [Abstract][Full Text] [Related]
3. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
Labrie F; Kelly PA; Asselin J; Raynaud JP
Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity.
Jones CD; Jevnikar MG; Pike AJ; Peters MK; Black LJ; Thompson AR; Falcone JF; Clemens JA
J Med Chem; 1984 Aug; 27(8):1057-66. PubMed ID: 6431104
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
7. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
Jordan VC
Breast Cancer Res Treat; 1983; 3 Suppl():S73-86. PubMed ID: 6423014
[TBL] [Abstract][Full Text] [Related]
8. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
[TBL] [Abstract][Full Text] [Related]
9. Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs.
Simard J; Labrie F
Mol Cell Endocrinol; 1985 Feb; 39(2):141-4. PubMed ID: 3884413
[TBL] [Abstract][Full Text] [Related]
10. Suppression of spontaneous LH surges in estrogen-treated ovariectomized rats by microimplants of antiestrogens into the preoptic brain.
Petersen SL; Barraclough CA
Brain Res; 1989 Apr; 484(1-2):279-89. PubMed ID: 2713688
[TBL] [Abstract][Full Text] [Related]
11. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
[TBL] [Abstract][Full Text] [Related]
12. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
13. Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model.
Robinson SP; Mauel DA; Jordan VC
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1817-21. PubMed ID: 2975594
[TBL] [Abstract][Full Text] [Related]
14. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
Tominaga T; Yoshida Y; Shimozuma K; Hayashi K; Kosaki G
Eur J Cancer; 1990; 26(5):600-3. PubMed ID: 2144748
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
Luo S; Sourla A; Labrie C; Bélanger A; Labrie F
Endocrinology; 1997 Oct; 138(10):4435-44. PubMed ID: 9322961
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
Van Ginckel R; Janssens B; Callens M; Goeminne N; Wouters L; De Coster R
Cancer Chemother Pharmacol; 1996; 38(1):21-8. PubMed ID: 8603447
[TBL] [Abstract][Full Text] [Related]
17. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
[TBL] [Abstract][Full Text] [Related]
18. [Plasma hormone levels in rats with DMBA-induced mammary tumors].
Burenin IS; Piskareva NK
Eksp Onkol; 1984; 6(1):24-7. PubMed ID: 6094141
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-like effects of 7,12-dimethylbenz(a)anthracene on the female rat hypothalamo-pituitary axis.
Pasqualini C; Sarrieau A; Dussaillant M; Corbani M; Bojda-Diolez F; Rostène W; Kerdelhué B
J Steroid Biochem; 1990 Aug; 36(5):485-91. PubMed ID: 2145477
[TBL] [Abstract][Full Text] [Related]
20. The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumours.
Nicholson RI; Golder MP
Eur J Cancer (1965); 1975 Aug; 11(8):571-9. PubMed ID: 816655
[No Abstract] [Full Text] [Related]
[Next] [New Search]